Abbott Laboratories (NYSE:ABT)
| 36.59 Data as of May 17 |  -0.24 / -0.65%Today’s Change | 28.45 Today|||52-Week Range 37.70 | +16.75% Year-to-Date |
Latest ABT News | Press Releases
| Abbott Laboratories (ABT): Today's Featured Health Services Winner May 14 / TheStreet.com | 5 Stocks Boosting The Health Services Industry Higher May 13 / TheStreet.com |
| 'Mad Money' Lightning Round: Valero Isn't What It Was May 14 / TheStreet.com | Covidien Provides 2013 Outlook - Analyst Blog May 06 / Zacks.com |
| Cramer's 'Mad Money' Recap: A Surreal Market May 13 / TheStreet.com |
Today’s Trading
| Previous close | 36.83 |
| Today’s open | 36.82 |
| Day’s range | 36.29 - 36.94 |
| Volume | 7,050,721 |
| Average volume (3 months) | 7,333,129 |
| Market cap | $57.0B |
| Dividend yield | 1.53% |
Data as of 4:04pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | +24.45% |
| Earnings growth (this year) | -17.00% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | +2.63% |
| P/E ratio | 11.1 |
| Price/Sales | 2.59 |
| Price/Book | 2.16 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CELGCelgene Corp | +1.43 | +1.16% |
| LLYEli Lilly and Co | -0.04 | -0.07% |
| AZNAstraZeneca PLC | -0.27 | -0.52% |
| BMYBristol-Myers Squibb... | +0.53 | +1.24% |
Data as of 4:02pm ET, 05/17/2013
Financials
| Next reporting date | July 17, 2013 |
| EPS forecast (this quarter) | $0.44 |
| Annual revenue (last year) | $39.9B |
| Annual profit (last year) | $6.0B |
| Net profit margin | 14.95% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer Miles D. White, MBA |
Chief Financial Officer & Executive Vice President Thomas C. Freyman, CPA |
Corporate headquarters Abbott Park, Illinois |
Forecasts
